Enhanced antitumor activity of cucurbitacin B combined with cerulenin in osteosarcoma

Authors

  • Zhe Zhang Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  • Ying Shen Xianning Central Hospital, Xianning 437100, China
  • Jian Wu Xianning Central Hospital, Xianning 437100, China
  • Lin Cai Zhongnan Hospital of Wuhan University, Wuhan 430071, China http://orcid.org/0000-0002-2358-7567

DOI:

https://doi.org/10.3329/bjp.v10i4.24601

Keywords:

Cerulenin, Cucurbitacin B, Osteosarcoma, Tumor

Abstract

In the present study, the effect of cucurbitacin B and cerulenin combination on osteosarcoma was investigated to develop an effective treatment regimen. The IC50 values of cerulenin and cucurbitacin B combination in the proportion of 1:1, 1:2 and 2:1 were  3.5, 7.2 and 8.6 μg/mL, respectively. The combination index (CI) values of <0.95 for inhibition of growth and <0.93 for inhibition of SENP5 expression clearly indicated synergism between the two. The Q-value for combination of 1 μg/mL cerulenin and 1 μg/mL cucurbitacin B was 1.2. AI calculated for tumor tissues treated with a combination of cucurbitacin B and cerulenin (26.2 ± 8.4%) was higher than that of the tissues treated separately with cucurbitacin B (14.5 ± 6.8%) or cerulenin (12.6 ± 7.5%). The AI for untreated tumor tissues was 4.2 ± 1.5%. Thus, the combination of cucurbitacin B and cerulenin can be a promising regimen in the treatment of osteosarcoma.

Downloads

Download data is not yet available.
Abstract
204
Download
105 Read
68

Downloads

Additional Files

Published

2015-11-19

How to Cite

Zhang, Z., Y. Shen, J. Wu, and L. Cai. “Enhanced Antitumor Activity of Cucurbitacin B Combined With Cerulenin in Osteosarcoma”. Bangladesh Journal of Pharmacology, vol. 10, no. 4, Nov. 2015, pp. 956-61, doi:10.3329/bjp.v10i4.24601.

Issue

Vol. 10 No. 4 (2015)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).